ANXA5 and neoplasm: Flow cytometric analysis of viable, 7-AAD- and Annexin-V-negative CX+ tumor cells either untreated (Ctrl) or after treatment with a sublethal dose of 1 phenyl-2-hexadecanoyl amino-3-morpholino-1-propanol (PPMP1, 25 μM) for 3 or 6 days.